Posicionamiento para el manejo de la hipertensión arterial en atención primaria a partir del análisis crítico de las guías americana (2017) y europea (2018). Sociedad Española de Médicos de Atención Primaria (SEMERGEN)

  1. V. Pallarés-Carratalá 12
  2. J.A. Divisón Garrote 34
  3. M.A. Prieto Díaz 5
  4. L. García Matarín 6
  5. M.C. Seoane Vicente 7
  6. F. Molina Escribano 8
  7. S. Velilla Zancada 9
  8. D. Rey Aldanaj 10
  9. S. Cinza Sanjurjo 1112
  10. C. Santos Altozano 13
  11. J.L. Górriz 1415
  12. F.J. Alonso Moreno 16
  13. J. Polo García 17
  14. A. Barquilla García 18
  15. P. Beato Fernández 19
  16. C. Escobar Cervantes 20
  1. 1 Unidad de Vigilancia de la Salud, Unión de Mutuas, Castellón, España
  2. 2 Universitat Jaume I, Castellón, España
  3. 3 Centro de Salud Casas Ibañez, Casas Ibáñez, Albacete, España
  4. 4 Universidad Católica San Antonio de Murcia, Murcia, España
  5. 5 Centro de Salud Vallobín-La Florida, Oviedo, España
  6. 6 Centro de Salud de Vícar, Vícar, Almería, España
  7. 7 Centro de Salud Acequión, Torrevieja, Alicante, España
  8. 8 Centro de Salud Casas Ibañez, Consultorio Balsa de Ves, Balsa de Ves, Albacete, España
  9. 9 Centro de Salud de Nájera, Nájera, La Rioja, España
  10. 10 Centro de Salud A Estrada, A Estrada, Pontevedra, España
  11. 11 Universidad de Santiago de Compostela, Santiago de Compostela, A Coruña, España
  12. 12 Centro de Salud Porto do Son, Porto de Son, A Coruña, España
  13. 13 Centro de Salud Suerte de Saavedra, Badajoz, España
  14. 14 Servicio de Nefrología, Hospital Clínico de Valencia, Valencia, España
  15. 15 Facultad de Medicina, Universidad de Valencia, Valencia, España
  16. 16 Centro de Salud Sillería, Toledo, España
  17. 17 Centro de Salud Casar de Cáceres, Casar de Cáceres, Cáceres, España
  18. 18 Centro de Salud de Trujillo, Trujillo, Cáceres, España
  19. 19 CAP Premià, Premià de Mar, Premià de Mar, Barcelona, España
  20. 20 Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España
Show affiliations +
Journal:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2019

Issue: 4

Pages: 251-272

Type: Article

DOI: 10.1016/J.SEMERG.2019.02.003 PMID: 31005506 SCOPUS: 2-s2.0-85064327218 DIALNET GOOGLE SCHOLAR

More publications in: Semergen: revista española de medicina de familia

Abstract

The Scientific Societies of Primary Care, being the area in which there is a considerable prevalence of Arterial Hypertension (AHT), need to periodically evaluate the international guidelines for its management. This is particularly relevant when disparate guidelines make it difficult to make decisions in daily clinical practice. The present document has as its aim to analyse the changes and new developments proposed in the guidelines of the American College of Cardiology and the American Heart Association (ACC/AHA 2017), as well as in the guidelines of the European Society of Cardiology and European Society of Hypertension (ESC/ESH 2018). An analysis will be made of any differences, limitations, and their applicability to Primary Care in Spain. Finally, the most relevant available and appropriate information is extracted and integrated in order to homogenise the care of the hypertensive patient, from a critical, but also a reasoned, perspective. The discrepancies between the recommendations in such essential aspects as the management of the disease, require the compiling and critical analysis of the information that enables us as scientific society, interested in providing all PC physicians with the most relevant, and at the same time, sensible, recommendations of all the guidelines.

Bibliographic References

  • T. Beaney, A.E. Schutte, M. Tomaszewski, C. Ariti, L.M. Burrell, R.R. Castillo, et al., MMM Investigators May Measurement Month 2017: An analysis of blood pressure screening results worldwide Lancet Glob Health., 6 (2018), pp. e736-e743 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • P.K. Whelton, R.M. Carey, W.S. Aronow, D.E. Casey Jr., K.J. Collins, C. Dennison Himmelfarb, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol., 71 (2018), pp. 2199-2269 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • B. Williams, G. Mancia, W. Spiering, E.A. Rosei, M. Azizi, M. Burnier, et al., ESC Scientific Document Group 2018 ESC/ESH Guidelines for the management of arterial hypertension Eur Heart J., 39 (2018), pp. 3021-3104 CrossRefView Record in ScopusGoogle Scholar
  • P. Muntner, R.M. Carey, S. Gidding, D.W. Jones, S.J. Taler, J.T. Wright Jr., et al. Population impact of the 2017 ACC/AHA High Blood Pressure Guideline J Am Coll Cardiol., 71 (2018), pp. 109-118 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • T. Gijón-Conde, M. Gorostidi, M. Camafort, M. Abad-Cardiel, E. Martín-Rioboo, F. Morales-Oliva, et al. Documento de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial Hipertens Riesgo Vasc., 35 (2018), pp. 119-129 ArticleDownload PDFGoogle Scholar
  • J.A. Divisón Garrote, J.R. Banegas, J.J. de la Cruz, C. Escobar Cervantes, A. de la Sierra, M. Gorostidi, et al. Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70.997 treated hypertensives J Am Soc Hypertens., 10 (2016), pp. 714-723 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • J. Hippisley-Cox, C. Coupland, P. Brindle Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: Prospective cohort study BMJ., 357 (2017), p. j2099 CrossRefGoogle Scholar
  • A. Mente, M. O’Donnell, S. Rangarajan, G. Dagenais, S. Lear, M. McQueen, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: A pooled analysis of data from four studies Lancet., 388 (2016), pp. 465-475 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • S. Beddhu, M.V. Rocco, R. Toto, T.E. Craven, T. Greene, U. Bhatt, et al. Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: A secondary analysis of a randomized trial Ann Intern Med., 167 (2017), pp. 375-383 CrossRefView Record in ScopusGoogle Scholar
  • S. Beddhu, T. Greene, R. Boucher, W.C. Cushman, G. Wei, G. Stoddard, et al. Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: Secondary analyses of two randomised controlled trials Lancet Diabetes Endocrinol., 6 (2018), pp. 555-563 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • B. Williams, T.M. MacDonald, S. Morant, D.J. Webb, P. Sever, G. McInnes, et al. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial Lancet., 386 (2015), pp. 2059-2068 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • S. Cinza Sanjurjo, M.A. Prieto Díaz, J.L. Llisterri Caro, V. Pallarés Carratalá, A. Barquilla García, L. Rodríguez Padial, et al. Características basales y manejo clínico de los primeros 3.000 pacientes incluidos en el estudio IBERICAN (Identificación de la población española de riesgo cardiovascular y renal) Semergen., 43 (2017), pp. 493-500 ArticleDownload PDFView Record in ScopusGoogle Scholar
Data source: Dialnet